Ads
related to: carcinoma in situ thyroid- DTC Treatment Option
HCPs: Learn About An Option For
Differentiated Thyroid Cancer.
- Dosing Information
Download A Dosing Guide &
View Safety Information.
- Safety Information
View Safety Information
For A DTC Treatment Option.
- Co-Pay Program
View Co-Pay Information
For Eligible DTC Patients.
- DTC Treatment Option
Search results
Results From The WOW.Com Content Network
Carcinoma in situ (CIS) is a group of abnormal cells. [ 1 ] [ 2 ] While they are a form of neoplasm , [ 3 ] there is disagreement over whether CIS should be classified as cancer . This controversy also depends on the exact CIS in question (e.g., cervical, skin, breast).
Carcinoma in situ is categorized stage 0; often tumors localized to the organ of origin are staged as I or II depending on the extent, locally extensive spread, to regional nodes are staged as III, and those with distant metastasis staged as stage IV. However, in some tumor types stage groups do not conform to this simplified schema.
Ductal carcinoma in situ, a condition sometimes called non-invasive or stage-zero breast cancer, ... New diagnoses of thyroid cancer in the U.S. are triple what they were 50 years ago, ...
Carcinoma is a malignancy that develops from epithelial cells. [1] Specifically, a carcinoma is a cancer that begins in a tissue that lines the inner or outer surfaces of the body, and that arises from cells originating in the endodermal, mesodermal [2] or ectodermal germ layer during embryogenesis.
Stage 0: carcinoma in situ, abnormal cells growing in their normal place ("in situ" from Latin for "in its place"). Stage 0 can also mean no remaining cancer after preoperative treatment in some cancers (e.g. colorectal cancer). Stage I: cancers are localized to one part of the body. Stage I cancer can be surgically removed if small enough.
More accurately, the actress revealed that she had an early stage of breast cancer called ductal carcinoma in situ (DCIS). The illness occurs when cells in the breast ducts become cancerous but ...